Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06077760 |
|---|---|
| Brief Title: | A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) |
| First Submitted : | October 5, 2023 |
| First Submitted that Met QC Criteria : | October 5, 2023 |
| First Posted : | October 11, 2023 |
| Last Update Submitted that Met QC Criteria : | April 17, 2024 |
| Last Update Posted : | April 18, 2024 |